Pharma

Your Article Summary

See Latest Articles

Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants
Cell Therapeutics, 07/30/09

Cell Therapeutics, Inc. announced the closing of its previously announced public offering of 33,731,923 shares of its common stock and warrants to purchase up to 8,432,981 shares of its common stock, including the underwriter's exercise of its overallotment option. The Company received approximately $40.3 million in net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09

Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09

 See all of Regulatory Issues